Dr. Reddys Labs (NYSE: RDY) reported Q2 EPS of $1.00, $0.05 better than the analyst estimate of $0.95. Revenue for the quarter came in at $921 million versus the consensus estimate of $874.08 million.

For earnings history and earnings-related data on Dr. Reddys Labs (RDY) click here.